Aura Biosciences, Inc. (AURA) — Stock Score Summary

Aura Biosciences, Inc. (AURA) has a MoatMap StockRank of 27/100 based on Quality (31/100), Value (35/100), and Momentum (49/100) factor scores. The current signal is SELL. Aura Biosciences is a clinical-stage oncology biotech. It lacks commercialized products, positive cash flows, or a proven reinvestment runway, making it unsuitable for a concentrated portfolio of quality compounders.

Aura Biosciences, Inc. is a clinical-stage biotechnology company developing virus-like drug conjugates (VDCs) for the treatment of ocular oncology. Its lead product candidate, belzupacap sarotalocan (AU-011), is being developed for ocular melanoma, a rare and aggressive eye cancer. The company's innovative VDC platform represents a novel approach to targeted cancer therapy, addressing unmet medical needs in underserved indications.

Key Financial Metrics

Price$6.35
Market Cap$775M
P/E (Forward)-3.35
Price/Book4.07
Return on Equity-95.6%
Return on Invested Capital-74.7%
Debt/Equity15.84
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-52M

Aura Biosciences, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Aura Biosciences, Inc.’s (AURA) StockRank?
MoatMap’s StockRank for Aura Biosciences, Inc. (AURA) is 27/100, with a Sell signal. It is a composite of Quality (31), Value (35), and Momentum (49) factor ranks across MoatMap’s 19,000+ stock universe.
Does Aura Biosciences, Inc. have an economic moat?
Aura Biosciences, Inc. (AURA) has a Quality factor score of 31/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Aura Biosciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Aura Biosciences, Inc. (AURA) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Aura Biosciences, Inc. in?
Aura Biosciences, Inc. (AURA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksAURA deep dive reportAI ChampionsHow we score stocksSense-check another stock